L-DOPA attenuates hyperactivity of Roborovskii hamsters

Behavioural Pharmacology

Volumn 20, Issue 3, 2009, Pages 260-264

  Kabuki, Yusuke ^a   Shigemi, Kazutaka ^a   Hamasu, Kousuke ^a   Furuse, Mitsuhiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dopamine; L 3,4 dihydroxyphenylalanine; Locomotor activity; Open field; Roborovskii hamster

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CARBIDOPA; DOPAMINE; LEVODOPA; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OPEN FIELD TEST; PHODOPUS; PHODOPUS ROBOROVSKII; SEROTONIN BLOOD LEVEL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CRICETINAE; DOPAMINE; DOPAMINE AGENTS; HYPERKINESIS; LEVODOPA; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; SEROTONIN;

EID: 67649528694     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32832c7111     Document Type: Article

References (29)

1. Antoniou K, Kafetzopoulos E, Papadoupoulou-Daifoti Z, Hyphantics T, Marselos M (1998). D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 23:189-196.
2. Arnsten AFT (2006). Fundamentals of attention-deficit/hyperactivlty disorder: circuits and pathways. J Clin Psychiatry 67:7-12.
3. Avale ME, Nemirovsky SI, Raisman-Vozari R, Rubinstein M (2004). Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. J Neurosci Res 78:289-296.
4. Bailey R, Crisp E, Jackson DM, Jenkins O (1981). Chronic L-DOPA treatment of mice: a behavioural and biochemical study. J Neural Transm 50:209-224.
5. Beichenberg K, Vetulani J (1973). Intraventricular injections of L-DOPA: the effect on rat locomotor activity and body temperature. Eur J Pharmacol 22:376-379.
6. Biederman J, Faraone SV (2005). Attention-deficit hyperactivity disorder. Lancet 366:237-248.
7. Buu NT (1989). Vesicular accumulation of dopamine following L-DOPA administration. Biochem Pharmacol 38:1787-1792.
8. Davids E, Zhang K, Tarazi Fl, Baldessarinl RJ (2003). Animal model of attention-deficit hyperactivity disorder. Brain Res Rev 42:1-21.
9. Diederich C, Milakofsky L, Hare TA, Hofford JM, Dadmarz M, Vogel WH (1997). Effects of L-DOPA/carbidopa administration on the level of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the rat. Pharmacology 55:109-116.
10. Diez JA, Ward WG, Summer GK (1976). Tryptophan transport in brain synaptosomes: effect of L-DOPA. Brain Res 118:534-539.
11. Doshi PS, Edwards DJ (1981). Effects of L-DOPA on dopamine and norepinephrine concentrations in rat brain assessed by gas chromatography. J Chromatogr 210:505-511.
12. Faraone SV, Biederman J (1998). Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951-958.
13. Hefti F, Melamed E (1981). Dopamine release in rat striatum after administration of L-DOPA as studied with in vivo electrochemistry. Brain Res 225: 333-346.
14. Kabuki Y, Yamane H, Hamasu K, Furuse M (2008). Different locomotor activities and monoamine levels in the brains of Djungarian hamsters (D. sungorus) and Roborovskli hamsters (D. roborovskli). Exp Anim 57:447-462.
15. Karobath M, Diaz JL, Huttunen M (1972). Serotonin synthesis with rat brain synaptosomes. Biochem Pharmacol 21:1245-1251.
16. Kohno Y (1981). Effect of L-DOPA on brain serotonin metabolism related to tryptophan concentrations in plasma and brain of rats. Nippon Yakurigaku Zasshi 77:281-293.
17. Koshimura K, Ohue T, Akiyama Y, ltoh A, Miwa S (1992). L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci 51:747-755.
18. Kramarcy NR, Brown JW, Thurmond JB (1984). Effects of drug-induced changes in brain monoamines of aggression and motor behavior in mice. Eur J Pharmacol 22:376-379.
19. Leo D, Sorrentino E, Volpicelli F, Eyman M, Greco D, Vigglano D, et al. (2003). Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci Biobehav Rev 27:661-669.
20. Luescher UA (1993). Hyperkinesia in dogs: six case reports. Can Vet J 34:368-370.
21. Myers MM, Musty RE, Hendley ED (1982). Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav Neural Biol 34:42-54.
22. Olds ME, Fobes JL, Albert V (1981 ). Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamlne. Psychopharmacology (Berl) 73:31-33.
23. Olijslagers JE, Werkman TR, McCreary AC, Kruse CG, Wadman WJ (2006). Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action. Curr Neuropharmacol 4:59-68.
24. Russel VA (2002). Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res 130: 191-196.
25. Snyder GL, Zigmond MJ (1990). The effects of L-DOPA on in vitro dopamine release from striatum. Brain Res 508:181-187.
26. Spencer TJ, Biederman J, Mick E (2007). Attention-deficit/hyperactlvity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 32:631-642.
27. Tomonaga S, Yamane H, Onitsuka E, Yamada S, Sato M, Takahata Y, et al. (2008). Carnosine-induced antidepressant-like activity in rats. Pharmacol Biochem Behav 89:627-632.
28. Viggiano D, Vallons D, Sadile A (2004). Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. Neural Plast 11:97-114.
29. Wiegand RG, Perry JE (1961). Effect of L-DOPA and N-methyl-N-benzyl-2- propynylamine. HCL on DOPA, dopamine, norepinephrine, epinephrine and serotonin levels in mouse brain. Biochem Pharmacol 7:181-186.